Learn more

BIODIM LAB

Overview
  • Total Patents
    50
  • GoodIP Patent Rank
    163,041
About

BIODIM LAB has a total of 50 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are LABORATOIRE BIODIM, OR YAT SUN and VSEROSSIJSKIJ NAUCHNYJ TS BEZO.

Patent filings per year

Chart showing BIODIM LABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Benarous Richard 29
#2 Ledoussal Benoit 29
#3 Chasset Sophie 28
#4 Chevreuil Francis 27
#5 Le Strat Frederic 16
#6 Atamanyuk Dmytro 15
#7 Gerusz Vincent 13
#8 Le Strat Frédéric 9
#9 Moreau Francois 8
#10 Faivre Fabien 8

Latest patents

Publication Filing date Title
EP2913330A1 Condensed derivatives of imidazole useful as pharmaceuticals
EP2913333A1 3H-thieno[3,4]pyrimidin-4-one and pyrrolopyrimidone as gram-positive antibacterial agents
EP2821104A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
EP2821082A1 Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use
EP2725029A1 New antibacterial compounds and biological applications thereof
EP2719685A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
EP2716639A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
EP2716632A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
WO2012172043A1 Purine derivatives and their use as pharmaceuticals for prevention or treatment of bacterial infections
EP2669288A1 New monosaccharide derivatives and biological applications thereof
EP2646451A2 Heptose derivatives for use in the treatment of bacterial infections
EP2508511A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
EP2376431A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
EP2014674A1 Protein-protein interactions in human immunodeficiency virus